 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Those holding RxSight, Inc. ( NASDAQ:RXST ) shares would be relieved that the share price has rebounded 28% in the last...

Revenues Tell The Story For RxSight, Inc. (NASDAQ:RXST) As Its Stock Soars 28%

American International Group Inc. increased its stake in shares of RxSight, Inc. (NASDAQ:RXST  Free Report) by 13.8% during the 2nd quarter, Holdings Channel reports. The institutional...

American International Group Inc. Has $376,000 Stock Holdings in RxSight, Inc. (NASDAQ:RXST)

RxSight, Inc. (NASDAQ:RXST  Get Free Report) Director Bakker Juliet Tammenoms sold 100,000 shares of the companys stock in a transaction dated Tuesday, November 14th. The stock was sold...

Bakker Juliet Tammenoms Sells 100,000 Shares of RxSight, Inc. (NASDAQ:RXST) Stock

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

RxSight management to meet with Oppenheimer

RxSight (NASDAQ:RXST  Get Free Report) had its price target dropped by analysts at Needham  Company LLC from $36.00 to $30.00 in a research report issued to clients and investors on...

RxSight (NASDAQ:RXST) PT Lowered to $30.00

Analyst Ryan Zimmerman of BTIG reiterated a Buy rating on RxSight (RXST Research Report), with a price target of $36.00. Ryan Zimmerman has given...

RxSight's Impressive Financial Performance and Growth Prospects: A Buy Rating Justified

ALISO VIEJO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...

RxSight, Inc. Reports Third Quarter 2023 Financial Results

ALISO VIEJO, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...

RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023

Investors considering a purchase of RxSight Inc (RXST) shares, but cautious about paying the going market price of 21.30/share, might benefit from considering selling puts among the alternative...

Commit To Buy RxSight At $15, Earn 12.7% Annualized Using Options

Shares of RxSight, Inc. (NASDAQ:RXST  Get Free Report) fell 3% during trading on Tuesday . The company traded as low as $25.88 and last traded at $25.88. 3,679 shares were traded during...

RxSight (NASDAQ:RXST) Trading Down 3%

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Watchers	139
52-Wk Low	$10.29
52-Wk High	$33.77

Market Cap	$1.08B
Volume (M)	559,529.00
52-Wk High	$33.77
52-Wk Low	$10.29

RXST RxSight Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community